MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$4,917,796
Marketable securities
$1,405,057
Prepaid expenses & other
current assets
$734,407
Total current assets
$7,057,260
Operating lease
right-of-use assets
$56,868
Deferred offering costs
$54,827
Property and equipment,
net
$28,022
Other assets
$26,090
Total assets
$7,223,067
Total liabilities and
stockholders equity
$7,223,067
Total liabilities
$3,777,366
Total stockholders
equity
$3,445,701
Accumulated deficit
-$96,474,226
Accumulated other
comprehensive (loss) income
-$35,637
Total current
liabilities
$3,777,366
Additional paid-in capital
$99,954,439
Common stock
(25,000,000 authorized at...
$1,125
Accounts payable and
accrued expenses
$3,718,290
Operating lease
liabilities, current
$59,076
Back
Back
Balance Sheet
source: myfinsight.com
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)